DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Gold M, Alderton C, Zvartau-Hind M , et al.
Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study.
Dement Geriatr Cogn Disord 2010;
30 (2) 131-146
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.